High Reproducibility of Tumor Hypoxia Evaluated by 18F-Fluoromisonidazole PET for Head and Neck Cancer
暂无分享,去创建一个
Keiichi Magota | Tohru Shiga | Hiroki Shirato | Katsuhiko Kasai | Koichi Yasuda | Nagara Tamaki | Yoichi M Ito | Yoichi M. Ito | Yuji Kuge | H. Shirato | T. Shiga | N. Tamaki | Keiichi Magota | Y. Kuge | K. Yasuda | Shozo Okamoto | Shozo Okamoto | Katsuhiko Kasai | Y. Ito
[1] Wade P. Smith,et al. Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] Seung Do Ahn,et al. Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[4] Vladimir Y. Panin,et al. Fully 3-D PET reconstruction with system matrix derived from point source measurements , 2006, IEEE Transactions on Medical Imaging.
[5] Christine Bayer,et al. Acute versus chronic hypoxia: why a simplified classification is simply not enough. , 2011, International journal of radiation oncology, biology, physics.
[6] J. Steinbach,et al. Two or four hour ( 18 F)FMISO-PET in HNSCC is the contrast best? , 2011 .
[7] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] Simon R. Cherry,et al. Improved Detection of Focal Cerebral Blood Flow Changes Using Three-Dimensional Positron Emission Tomography , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] Daniela Thorwarth,et al. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia , 2005, Physics in medicine and biology.
[10] J. Eary,et al. [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Matthias Reimold,et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] D. Townsend,et al. Physical and clinical performance of the mCT time-of-flight PET/CT scanner , 2011, Physics in medicine and biology.
[13] J. Steinbach,et al. Two or four hour [18F]FMISO-PET in HNSCC , 2011, Nuklearmedizin.
[14] David L. Schwartz,et al. Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.
[15] Heinz H. Coenen,et al. pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. , 2004 .
[16] Sigrid Stroobants,et al. Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.
[17] M. Lodge,et al. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] Sadek Nehmeh,et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. , 2008, International journal of radiation oncology, biology, physics.
[19] R. Onimaru,et al. [18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer. , 2013, International journal of radiation oncology, biology, physics.
[20] W. McBride,et al. Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited , 2010, Stem cells.
[21] Daniela Thorwarth,et al. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging , 2012, Physics in medicine and biology.
[22] Sadek Nehmeh,et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.
[23] Gig Mageras,et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[24] K L Lindsley,et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.
[25] R. Fisher,et al. Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] T W Griffin,et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.
[27] G. W. Snedecor. Statistical Methods , 1964 .
[28] John A. Cornell,et al. Statistical Methods (7th ed.) , 2012 .
[29] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[30] Max A. Viergever,et al. Mutual-information-based registration of medical images: a survey , 2003, IEEE Transactions on Medical Imaging.